Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

eprazinone

Known as: 3-(4-(beta-ethoxyphenethyl)-1-piperazinyl)-2-methylpropiophenone, 1-(2-phenyl-2-ethoxy)ethyl-4-(2-benzyloxy)propylpiperazine, Éprazinone 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Neurokinin receptors (NKRs) have been shown to be involved in many physiological processes, rendering them promising novel drug… Expand
1992
1992
Eprazinone therapy improves pulmonary function and arterial pO2 in patients with chronic bronchitis; however, the mechanism of… Expand
1991
1991
The crystal structure of eprazinone dihydrochloride, 2HCl, has been determined from 2102 independent reflections collected on an… Expand
1985
1985
 
1984
1984
A drug eruption with subcorneal pustulation is presented, occurring in a patient during treatment with eprazinone . The biopsy of… Expand
1981
1981
After oral application of 3-[4-(beta-ethoxyphenethyl)-1-piperazinyl]-2-methylpropiophenone dihydrochloride (eprazinone, Eftapan… Expand
1980
1980
This study should demonstrate the efficiency of a new bronchosecretolytic substance, Eprazinone, in therapy of acute and chronic… Expand
1977
1977
Perry and Boyd's method described in 1941 appears to be the most suitable for evaluating the efficacy of expectorants. In this… Expand
1976
1976
The study of therapeutical agents for "mucolysis" enables a classification of these drugs from their mode of action at the… Expand